Exploring new approaches to fetal monitoring
Approach. We're investigating how emerging technologies could enable earlier detection of fetal distress through more frequent, accessible monitoring.
Research areas
| Area | Description |
|---|---|
| Growth trajectory analysis | Investigating how individualized growth curves, rather than population-based percentiles, could improve early identification of growth restriction. |
| AI-assisted interpretation | Researching machine learning approaches to interpreting complex fetal data, enabling detection of subtle patterns that indicate developing complications. |
| Multi-modal sensing | Exploring how combining multiple sensor modalities could provide complementary signals for fetal wellbeing assessment in non-clinical settings. |
| Clinical integration | Studying how continuous monitoring data could integrate with existing clinical pathways, supporting clinical care. |
Note. Our research is ongoing. We are currently in early-stage feasibility studies and are not making claims about clinical efficacy. We are committed to rigorous validation through proper clinical trials.
References
Our work builds on decades of research in maternal-fetal medicine, ultrasound imaging, and AI-assisted diagnostics.
- Saving babies and families from preventable harm: the current state of fetoplacental monitoring
- Fetal growth restriction and stillbirth: biomarkers for identifying at-risk fetuses
- Prediction of preterm birth using artificial intelligence: a systematic review
- Prenatal care services, maternal morbidity, and perinatal mortality with the advanced maternal age cutoff
- International standards for fetal growth based on serial ultrasound measurements: the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project
- Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the TRUFFLE study
Participate
We are enrolling people in their second or third trimester of pregnancy in a voluntary, IRB-reviewed feasibility study of an investigational wearable fetal monitoring device. Open to participants in the United States.